ONC – BeOne Medicines Ltd ADR

ONC — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

0.91

Margin Of Safety %

-20

Put/Call OI Ratio

0.65

EPS Next Q Diff

-0.31

EPS Last/This Y

-1.52

EPS This/Next Y

3.15

Price

348.31

Target Price

426.91

Analyst Recom

1.18

Performance Q

9.86

Upside

-42.8%

Beta

0.5

Ticker: ONC

19 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-07-14	ONC	306.37	0.74	0.18	2353
2026-07-15	ONC	311.3	0.74	0.50	2358
2026-07-16	ONC	317.24	0.74	0.83	2361
2026-07-17	ONC	312.31	0.74	0.67	2361
2026-07-20	ONC	310.64	0.74	9.00	2175
2026-07-21	ONC	318.87	0.76	0.45	2203
2026-07-22	ONC	320.01	0.75	1.00	2235
2026-07-23	ONC	326.48	0.74	0.00	2248
2026-07-24	ONC	325.64	0.74	0.83	2257
2026-07-27	ONC	325.84	0.74	0.43	2259
2026-07-28	ONC	330.28	0.74	2.00	2261
2026-07-29	ONC	327.14	0.74	0.00	2267
2026-07-30	ONC	321.9	0.75	0.04	2262
2026-07-31	ONC	315.74	0.61	0.00	2598
2026-08-03	ONC	313.87	0.61	0.44	2598
2026-08-04	ONC	323.21	0.61	0.11	2612
2026-08-05	ONC	327.36	0.62	0.91	2577
2026-08-06	ONC	330.12	0.65	0.19	2887
2026-08-07	ONC	348.25	0.65	3.63	2900
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

19 items 1 of 1

19 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-07-14	ONC	306.32	77.5	80.3	6.43
2026-07-15	ONC	310.93	77.5	91.6	6.43
2026-07-16	ONC	317.71	80.9	97.9	6.44
2026-07-17	ONC	311.82	80.9	71.8	6.44
2026-07-20	ONC	312.02	80.9	100.6	6.44
2026-07-21	ONC	318.66	80.9	94.5	6.44
2026-07-22	ONC	319.58	80.9	83.1	6.44
2026-07-23	ONC	327.90	80.9	91.6	6.44
2026-07-24	ONC	326.87	80.9	102.0	6.44
2026-07-27	ONC	326.94	87.4	81.1	6.44
2026-07-28	ONC	330.14	89.7	86.6	6.47
2026-07-29	ONC	326.90	89.7	100.0	6.47
2026-07-30	ONC	322.86	92.7	70.8	6.55
2026-07-31	ONC	315.72	92.7	66.5	6.55
2026-08-03	ONC	313.45	94.2	69.5	6.54
2026-08-04	ONC	313.45	94.2	69.5	6.54
2026-08-05	ONC	327.51	94.2	109.3	6.54
2026-08-06	ONC	329.63	94.2	102.4	6.54
2026-08-07	ONC	348.31	94.2	-80.1	6.54
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

19 items 1 of 1

19 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-07-14	ONC	-7.18	-0.48	0.78
2026-07-15	ONC	-31.73	-0.48	0.78
2026-07-16	ONC	-31.73	-0.48	0.78
2026-07-17	ONC	-31.73	-0.48	0.78
2026-07-20	ONC	-52.80	-0.49	0.78
2026-07-21	ONC	-52.80	-0.49	0.78
2026-07-22	ONC	-52.80	-0.49	0.78
2026-07-23	ONC	-56.98	-0.49	0.78
2026-07-24	ONC	-56.98	-0.49	0.78
2026-07-27	ONC	-57.04	-0.67	0.91
2026-07-28	ONC	-57.04	-0.67	0.91
2026-07-29	ONC	-57.04	-0.67	0.91
2026-07-30	ONC	-57.04	-0.67	0.91
2026-07-31	ONC	-57.04	-0.67	0.91
2026-08-03	ONC	-57.04	-0.63	0.91
2026-08-04	ONC	-57.08	-0.63	0.91
2026-08-05	ONC	-57.12	-0.63	0.91
2026-08-06	ONC	-57.12	-0.63	0.91
2026-08-07	ONC	-57.06	-0.63	0.91
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

19 items 1 of 1

Last Quarter Act. EPS

2.05

Avg. EPS Est. Current Quarter

1.63

Avg. EPS Est. Next Quarter

1.74

Insider Transactions

-57.06

Institutional Transactions

-0.63

Beta

0.5

Average Sales Estimate Current Quarter

1594

Average Sales Estimate Next Quarter

1678

Fair Value

277.52

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

18.3

Max Drawdown 5-Year %

-70

Target Price

426.91

P/E

61.2

Forward P/E

35.41

PEG

0.5

P/S

5.8

P/B

7.61

P/Free Cash Flow

26.72

EPS

5.69

Average EPS Est. Cur. Y

6.54

EPS Next Y. (Est.)

9.69

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

10.7

Relative Volume

Return on Equity vs Sector %

-14.6

Return on Equity vs Industry %

1.4

EPS 1 7Days Diff

0.1

EPS 1 30Days Diff

-0.05

EBIT Estimation

-80.1

◆ ONC Healthcare

$348.27

📉

Swing / Pullback

Buy the dip on strong trends

WEAK

Trend

20/20

Pullback

4/25

Volume

3/15

Valuation

13/20

TP/AR

2/10

Options

6/10

RSI

73.2

Range 1M

91.2%

Sup Dist

6.4%

🚀

Momentum Growth

Ride accelerating trends

WATCH

Momentum

18/25

Growth

28/30

Estimates

5/20

Inst/Vol

5/15

Options

3/10

EPS Yr

170.8%

EPS NY

38.1%

52W%

69.4%

💎

Long-Term Value

Quality companies, undervalued

WEAK

🔴 SELL -2.9% upside

Quality

15/30

Valuation

2/30

Growth

20/25

Stability

4/10

LT Trend

4/5

Upside

-2.9%

Quality

MoS

-20%

ONC — P/E HistoricalBiotechnology

BeOne Medicines Ltd.

Sector: Healthcare

Industry: Biotechnology

Employees: 12000

BeOne Medicines AG, an oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally. The company's commercial stage products include BRUKINSA, a small molecule inhibitor of Bruton's Tyrosine Kinase (BTK) for the treatment of various blood cancers; TEVIMBRA, an anti-PD-1 antibody immunotherapy for the treatment of various solid tumor and blood cancers; SYLVANT for the treatment of adult patients with multicentric castleman disease; BAITUOWEI for patients with BC in premenopausal and perimenopausal women, and cancer; and PARTRUVIX for the treatment of various solid tumors. Its clinical stage products comprise Sonrotoclax BGB-11417, a small molecule Bcl-2 inhibitor; BGB-16673, a BTK targeting chimeric degradation activation compound active against wild type and mutant BTK; BG-60366, an EGFR-targeted CDAC; BG-89894 (SYH2039), a MAT2A Inhibitor; BGB-58067, an MTA-Cooperative PRMT5 Inhibitor; BG-T187 and BG-C0902, an anti-EGFRxMET trispecific antibody; BGB-26808, a HPK-1 Inhibitor; BGB-C354, an anti-B7H3 ADC; Zanidatamab, a bispecific HER2-targeted antibody; BG-C137, an anti-FGFR2b ADC; BGB-53038, a Pan-KRAS Inhibitor; BGB-B2033, an anti-GPC3x4-1BB bispecific antibody; BGB-B3227, an anti-MUC1xCD16A bispecific antibody; BG-C477, an anti-CEAADC; BGB-43395, a CDK4 Inhibitor; BG-68501, a CDK2 Inhibitor; BG-C9074, an anti-B7H4 ADC; BGB-21447, a Bcl-2 Inhibitor; and BGB-45035, an IRAK4-targeted CDAC. It also has various preclinical programs. The company has agreements Amgen, BMS, Bio-Thera, EUSA Pharma, Luye Pharmaceutical, and Novartis. The company was formerly known as BeiGene, Ltd. and changed its name to BeOne Medicines AG in May 2025. BeOne Medicines AG was founded in 2010 and is based in Basel, Switzerland.

ONC

Latest News

—

Caricamento notizie per ONC…

stock quote shares ONC – BeOne Medicines Ltd ADR Stock Price stock today

news today ONC – BeOne Medicines Ltd ADR stock forecast ,stock prediction 2023 2024 2025

marketwatch ONC – BeOne Medicines Ltd ADR yahoo finance google finance

stock history ONC – BeOne Medicines Ltd ADR invest stock market

stock prices ONC premarket after hours

ticker ONC fair value insiders trading

AMRZ – Amrize Ltd

AMRZ — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

1.69

Margin Of Safety %

Put/Call OI Ratio

1.09

EPS Next Q Diff

1.32

EPS Last/This Y

0.54

EPS This/Next Y

0.42

Price

46.83

Target Price

62.02

Analyst Recom

1.88

Performance Q

-12.59

Upside

2.4%

Beta

0.14

Ticker: AMRZ

19 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-07-14	AMRZ	49.78	0.84	0.37	36748
2026-07-15	AMRZ	50.76	0.82	4.35	36739
2026-07-16	AMRZ	51.16	0.83	0.88	37037
2026-07-17	AMRZ	49.73	0.83	0.37	36871
2026-07-20	AMRZ	48.79	1.15	0.83	27749
2026-07-21	AMRZ	48.69	1.16	0.36	28021
2026-07-22	AMRZ	49.58	1.06	11.35	30154
2026-07-23	AMRZ	48.33	1.10	13.56	30904
2026-07-24	AMRZ	49.25	0.90	0.03	28282
2026-07-27	AMRZ	49.96	0.90	0.01	28304
2026-07-28	AMRZ	50.36	0.90	1.61	28263
2026-07-29	AMRZ	49.47	0.91	0.08	28435
2026-07-30	AMRZ	49.57	0.91	0.07	28428
2026-07-31	AMRZ	48.92	0.92	5.74	28353
2026-08-03	AMRZ	51.09	0.93	2.69	28574
2026-08-04	AMRZ	51.83	1.05	0.69	30387
2026-08-05	AMRZ	52.88	1.07	0.06	31148
2026-08-06	AMRZ	51.18	1.09	0.39	29528
2026-08-07	AMRZ	46.67	1.09	1.46	29883
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

19 items 1 of 1

19 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-07-14	AMRZ	49.77	0.7	332.4	2.68
2026-07-15	AMRZ	50.75	0.7	366.9	2.68
2026-07-16	AMRZ	51.17	0.7	372.4	2.68
2026-07-17	AMRZ	49.73	0.7	288.0	2.68
2026-07-20	AMRZ	48.79	0.7	274.2	2.68
2026-07-21	AMRZ	48.68	0.7	320.9	2.68
2026-07-22	AMRZ	49.58	0.7	361.9	2.68
2026-07-23	AMRZ	48.32	0.7	294.7	2.68
2026-07-24	AMRZ	49.24	-0.1	364.0	2.68
2026-07-27	AMRZ	49.97	-0.1	356.4	2.68
2026-07-28	AMRZ	50.39	-0.1	340.9	2.68
2026-07-29	AMRZ	49.47	-0.1	291.5	2.68
2026-07-30	AMRZ	49.58	-0.1	333.2	2.68
2026-07-31	AMRZ	48.93	-0.1	318.9	2.68
2026-08-03	AMRZ	51.10	-0.1	415.0	2.68
2026-08-04	AMRZ	51.10	-0.1	415.0	2.68
2026-08-05	AMRZ	52.87	-0.1	380.6	2.68
2026-08-06	AMRZ	51.23	-0.1	288.5	2.68
2026-08-07	AMRZ	46.83	-0.1	151.2	2.68
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

19 items 1 of 1

19 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-07-14	AMRZ	0.22	-4.07	1.79
2026-07-15	AMRZ	0.22	-4.07	1.79
2026-07-16	AMRZ	0.22	-4.07	1.79
2026-07-17	AMRZ	0.22	-4.07	1.79
2026-07-20	AMRZ	0.22	-4.06	1.79
2026-07-21	AMRZ	0.22	-4.06	1.79
2026-07-22	AMRZ	0.22	-4.06	1.79
2026-07-23	AMRZ	0.22	-4.06	1.79
2026-07-24	AMRZ	0.22	-4.06	1.79
2026-07-27	AMRZ	0.22	-4.74	1.69
2026-07-28	AMRZ	0.22	-4.74	1.69
2026-07-29	AMRZ	0.22	-4.74	1.69
2026-07-30	AMRZ	0.22	-4.74	1.69
2026-07-31	AMRZ	0.22	-4.74	1.69
2026-08-03	AMRZ	0.22	-4.67	1.69
2026-08-04	AMRZ	0.22	-4.67	1.69
2026-08-05	AMRZ	0.22	-4.67	1.69
2026-08-06	AMRZ	0.22	-4.67	1.69
2026-08-07	AMRZ	0.22	-4.67	1.69
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

19 items 1 of 1

Last Quarter Act. EPS

-0.16

Avg. EPS Est. Current Quarter

0.94

Avg. EPS Est. Next Quarter

1.16

Insider Transactions

0.22

Institutional Transactions

-4.67

Beta

0.14

Average Sales Estimate Current Quarter

3330

Average Sales Estimate Next Quarter

3826

Fair Value

52.68

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

62.02

P/E

21.45

Forward P/E

14.81

PEG

0.78

P/S

2.12

P/B

1.97

P/Free Cash Flow

19.54

EPS

2.17

Average EPS Est. Cur. Y

2.68

EPS Next Y. (Est.)

3.1

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

9.89

Relative Volume

3.15

Return on Equity vs Sector %

-7.8

Return on Equity vs Industry %

-1.5

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.01

EBIT Estimation

151.2

◆ AMRZ Basic Materials

$46.64

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

16/20

Pullback

13/25

Volume

0/15

Valuation

18/20

TP/AR

1/10

Options

2/10

RSI

38.1

Range 1M

1.6%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

14/25

Growth

18/30

Estimates

2/20

Inst/Vol

4/15

Options

3/10

EPS Yr

28.4%

EPS NY

14.6%

52W%

0.5%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +33.6% upside

Quality

5/30

Valuation

14/30

Growth

12/25

Stability

4/10

LT Trend

4/5

Upside

+33.6%

Quality

MoS

12%

AMRZ — P/E HistoricalBuilding Materials

Amrize Ltd

Sector: Basic Materials

Industry: Building Materials

Employees: 19000

Amrize AG engages in the provision of various building solutions for infrastructure, commercial, and residential construction markets in North America and Canada. It operates through two segments, Building Materials and Building Envelope. The Building Materials segment offers cement and aggregates, as well as ready-mix concrete, asphalt, and other construction materials. The Building Envelope segment provides advanced roofing and wall systems, including single-ply membranes, insulation, shingles, sheathing, waterproofing, and protective coatings; and adhesives, tapes, and sealants. The company was formerly known as Holcim North America Finance Ltd and changed its name to Amrize AG in December 2013. Amrize AG was incorporated in 2023 and is based in Zug, Switzerland.

AMRZ

Latest News

—

Caricamento notizie per AMRZ…

stock quote shares AMRZ – Amrize Ltd Stock Price stock today

news today AMRZ – Amrize Ltd stock forecast ,stock prediction 2023 2024 2025

marketwatch AMRZ – Amrize Ltd yahoo finance google finance

stock history AMRZ – Amrize Ltd invest stock market

stock prices AMRZ premarket after hours

ticker AMRZ fair value insiders trading

ADCT – Adc Therapeutics SA

ADCT — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

5.69

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

-0.01

EPS Last/This Y

0.26

EPS This/Next Y

0.19

Price

1.13

Target Price

4.7

Analyst Recom

2.33

Performance Q

-69.87

Upside

-3,352.2%

Beta

1.84

Ticker: ADCT

18 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-07-14	ADCT	1.23	0.02	0.00	4436
2026-07-15	ADCT	1.28	0.02	0.00	4619
2026-07-16	ADCT	1.35	0.02	0.00	4619
2026-07-17	ADCT	1.36	0.02	0.00	5038
2026-07-20	ADCT	1.26	0.01	0.00	1777
2026-07-21	ADCT	1.27	0.01	0.00	1836
2026-07-22	ADCT	1.24	0.01	0.00	1915
2026-07-23	ADCT	1.23	0.01	0.00	1917
2026-07-24	ADCT	1.17	0.01	0.00	2017
2026-07-27	ADCT	1.135	0.01	0.00	2088
2026-07-28	ADCT	1.11	0.01	0.00	2104
2026-07-29	ADCT	1.1	0.01	0.00	2362
2026-07-30	ADCT	1.125	0.01	0.00	2400
2026-07-31	ADCT	1.05	0.01	0.00	2417
2026-08-03	ADCT	1.05	0.01	0.00	2329
2026-08-04	ADCT	1.105	0.00	0.00	2338
2026-08-05	ADCT	1.075	0.00	0.00	2338
2026-08-07	ADCT	1.13	0.00	0.00	2371
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

18 items 1 of 1

19 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-07-14	ADCT	1.23	-	-	-0.86
2026-07-15	ADCT	1.28	-	-	-0.86
2026-07-16	ADCT	1.35	-	-	-0.86
2026-07-17	ADCT	1.36	-	-	-0.86
2026-07-20	ADCT	1.27	-	-	-0.86
2026-07-21	ADCT	1.27	-	-	-0.86
2026-07-22	ADCT	1.24	-	-	-0.86
2026-07-23	ADCT	1.22	-	-	-0.86
2026-07-24	ADCT	1.17	-	-	-0.86
2026-07-27	ADCT	1.13	-	-	-0.86
2026-07-28	ADCT	1.11	-	-	-0.86
2026-07-29	ADCT	1.10	-	-	-0.86
2026-07-30	ADCT	1.12	-	-	-0.86
2026-07-31	ADCT	1.05	-	-	-0.86
2026-08-03	ADCT	1.05	-	-	-0.86
2026-08-04	ADCT	1.05	-	-	-0.86
2026-08-05	ADCT	1.07	-	-	-0.86
2026-08-06	ADCT	1.12	-	-	-0.86
2026-08-07	ADCT	1.13	-	-	-0.86
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

19 items 1 of 1

19 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-07-14	ADCT	-16.42	1.41	6.16
2026-07-15	ADCT	-16.42	1.41	6.16
2026-07-16	ADCT	-16.42	1.41	6.16
2026-07-17	ADCT	-16.42	1.41	6.16
2026-07-20	ADCT	-16.42	1.49	6.16
2026-07-21	ADCT	-16.42	1.49	6.16
2026-07-22	ADCT	-16.42	1.49	6.16
2026-07-23	ADCT	-16.42	1.49	6.16
2026-07-24	ADCT	-16.42	1.49	6.16
2026-07-27	ADCT	-16.42	1.52	5.69
2026-07-28	ADCT	-16.42	1.52	5.69
2026-07-29	ADCT	-16.42	1.52	5.69
2026-07-30	ADCT	-16.42	1.52	5.69
2026-07-31	ADCT	-16.42	1.52	5.69
2026-08-03	ADCT	-16.42	1.23	5.69
2026-08-04	ADCT	-16.42	1.23	5.69
2026-08-05	ADCT	-16.42	1.23	5.69
2026-08-06	ADCT	-16.42	1.23	5.69
2026-08-07	ADCT	-16.42	1.23	5.69
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

19 items 1 of 1

Last Quarter Act. EPS

-0.21

Avg. EPS Est. Current Quarter

-0.22

Avg. EPS Est. Next Quarter

-0.22

Insider Transactions

-16.42

Institutional Transactions

1.23

Beta

1.84

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

96.5

Max Drawdown 5-Year %

-98.5

Target Price

4.7

P/E

Forward P/E

PEG

P/S

1.82

P/B

P/Free Cash Flow

EPS

-1.05

Average EPS Est. Cur. Y

-0.86

EPS Next Y. (Est.)

-0.66

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-173.02

Relative Volume

0.3

Return on Equity vs Sector %

Return on Equity vs Industry %

56.5

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

◆ ADCT Healthcare

$1.13

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

0/20

Pullback

17/25

Volume

11/15

Valuation

12/20

TP/AR

1/10

Options

5/10

RSI

40.3

Range 1M

22.1%

Sup Dist

3.5%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

0/25

Growth

14/30

Estimates

3/20

Inst/Vol

3/15

Options

5/10

EPS Yr

23.6%

EPS NY

22.6%

52W%

8.2%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +315.9% upside

Quality

7/30

Valuation

16/30

Growth

14/25

Stability

7/10

LT Trend

1/5

Upside

+315.9%

Quality

ADCT — P/E HistoricalBiotechnology

ADC Therapeutics SA

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Employees: 188

ADC Therapeutics SA provides antibody drug conjugate (ADC) technology platform in Switzerland and the United States. Its flagship product includes ZYNLONTA, a CD19-directed ADC, received accelerated approval from the U.S. Food and Drug Administration, conditional approval from the European Commission, and conditional approval from the China National Medical Products Administration for the treatment of relapsed or refractory diffuse large B-cell lymphoma (DLBCL) after two or more lines of systemic therapy. The company is also seeking to continue expanding ZYNLONTA into international markets and into earlier lines of DLBCL and indolent lymphomas, including follicular lymphoma (FL) and marginal zone lymphoma (MZL) as a single agent and in combination through its LOTIS-5 confirmatory Phase 3 clinical trial and LOTIS-7 Phase 1b clinical trial, as well as through investigator-initiated trials (IITs). In addition, it is investigating a CD-22 targeted compound' and ADCT-602 that is in a Phase 1/2 IIT in refractory B-cell acute lymphoblastic leukemia. Further, the company's pre-clinical stage pipeline includes a portfolio of next generation investigational ADCs targeting Claudin-6, NaPi2b, PSMA, NaPi2b, and ASCT2. ADC Therapeutics SA was incorporated in 2011 and is headquartered in Epalinges, Switzerland.

ADCT

Latest News

—

Caricamento notizie per ADCT…

stock quote shares ADCT – Adc Therapeutics SA Stock Price stock today

news today ADCT – Adc Therapeutics SA stock forecast ,stock prediction 2023 2024 2025

marketwatch ADCT – Adc Therapeutics SA yahoo finance google finance

stock history ADCT – Adc Therapeutics SA invest stock market

stock prices ADCT premarket after hours

ticker ADCT fair value insiders trading

CS – Credit Suisse Group AG

UBS – UBS Group AG

UBS — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

0.22

Margin Of Safety %

Put/Call OI Ratio

1.29

EPS Next Q Diff

0.12

EPS Last/This Y

0.91

EPS This/Next Y

0.71

Price

53.79

Target Price

53.23

Analyst Recom

2.65

Performance Q

Upside

91.4%

Beta

1.18

Ticker: UBS

19 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-07-14	UBS	53.82	1.27	0.08	100065
2026-07-15	UBS	55.06	1.25	0.07	100782
2026-07-16	UBS	53.51	1.23	1.21	101759
2026-07-17	UBS	52.76	1.23	0.84	103702
2026-07-20	UBS	51.5	1.27	0.18	99745
2026-07-21	UBS	52.35	1.31	0.63	98348
2026-07-22	UBS	52.67	1.32	0.19	98704
2026-07-23	UBS	51.56	1.29	1.12	100162
2026-07-24	UBS	51.74	1.29	0.52	100271
2026-07-27	UBS	52.55	1.29	0.44	100368
2026-07-28	UBS	52.03	1.29	1.64	100425
2026-07-29	UBS	51.8	1.29	1.06	101057
2026-07-30	UBS	53.38	1.30	0.77	102186
2026-07-31	UBS	52.72	1.29	0.17	102791
2026-08-03	UBS	52.75	1.30	0.98	102771
2026-08-04	UBS	53.47	1.30	0.03	102904
2026-08-05	UBS	53.58	1.26	4.47	104271
2026-08-06	UBS	52.86	1.29	1.01	105728
2026-08-07	UBS	53.79	1.29	0.59	105815
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

19 items 1 of 1

19 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-07-14	UBS	53.78	19.1	-	3.89
2026-07-15	UBS	55.07	19.1	-	3.89
2026-07-16	UBS	53.52	19.1	-	3.89
2026-07-17	UBS	52.71	19.1	-	3.89
2026-07-20	UBS	51.49	19.1	-	3.89
2026-07-21	UBS	52.34	19.1	-	3.34
2026-07-22	UBS	52.69	19.1	-	3.34
2026-07-23	UBS	51.54	19.1	-	3.34
2026-07-24	UBS	51.75	19.1	-	3.34
2026-07-27	UBS	52.54	19.1	-	3.34
2026-07-28	UBS	52.02	19.1	-	3.34
2026-07-29	UBS	51.83	19.1	-	3.34
2026-07-30	UBS	53.39	19.1	-	3.34
2026-07-31	UBS	52.71	5.0	-	3.34
2026-08-03	UBS	52.75	5.0	-	3.34
2026-08-04	UBS	52.75	5.0	-	3.34
2026-08-05	UBS	53.57	5.0	-	2.94
2026-08-06	UBS	52.85	5.0	-	2.94
2026-08-07	UBS	53.79	5.0	-	3.37
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

19 items 1 of 1

18 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-07-14	UBS	0.00	-10.95	0.23
2026-07-15	UBS	0.00	-10.95	0.23
2026-07-16	UBS	0.00	-10.95	0.23
2026-07-17	UBS	0.00	-10.95	0.23
2026-07-20	UBS	0.00	-9.91	0.23
2026-07-21	UBS	0.00	-9.91	0.23
2026-07-22	UBS	0.00	-9.91	0.23
2026-07-23	UBS	0.00	-9.91	0.23
2026-07-24	UBS	0.00	-9.91	0.23
2026-07-27	UBS	0.00	-9.96	0.22
2026-07-28	UBS	0.00	-9.96	0.22
2026-07-29	UBS	0.00	-9.96	0.22
2026-07-30	UBS	0.00	-9.96	0.22
2026-07-31	UBS	0.00	-9.96	0.22
2026-08-03	UBS	0.00	-5.09	0.22
2026-08-04	UBS	0.00	-5.09	0.22
2026-08-06	UBS	0.00	-5.09	0.22
2026-08-07	UBS	0.00	-5.09	0.22
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

18 items 1 of 1

Last Quarter Act. EPS

0.87

Avg. EPS Est. Current Quarter

0.96

Avg. EPS Est. Next Quarter

0.99

Insider Transactions

Institutional Transactions

-5.09

Beta

1.18

Average Sales Estimate Current Quarter

10754

Average Sales Estimate Next Quarter

10375

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

2.5

Max Drawdown 5-Year %

-32.5

Target Price

53.23

P/E

18.28

Forward P/E

12.7

PEG

0.63

P/S

2.04

P/B

1.85

P/Free Cash Flow

EPS

2.94

Average EPS Est. Cur. Y

3.37

EPS Next Y. (Est.)

4.08

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

11.82

Relative Volume

0.94

Return on Equity vs Sector %

-1.4

Return on Equity vs Industry %

-0.5

EPS 1 7Days Diff

EPS 1 30Days Diff

0.06

EBIT Estimation

◆ UBS Financial

$53.76

📉

Swing / Pullback

Buy the dip on strong trends

WEAK

Trend

12/20

Pullback

8/25

Volume

7/15

Valuation

3/20

TP/AR

0/10

Options

3/10

RSI

59.2

Range 1M

71.7%

Sup Dist

2.5%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

9/25

Growth

11/30

Estimates

2/20

Inst/Vol

1/15

Options

5/10

EPS Yr

32%

52W%

93.3%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +118% upside

Quality

5/30

Valuation

18/30

Growth

11/25

Stability

2/10

LT Trend

3/5

Upside

+118%

Quality

UBS — P/E HistoricalBanks - Diversified

UBS Group AG Registered

Sector: Financial Services

Industry: Banks - Diversified

Employees: 99085

UBS Group AG operates as a wealth manager and bank worldwide. It operates through five segments: Global Wealth Management, Personal & Corporate Banking, Asset Management, Investment Bank, and Non-Core and Legacy. The Global Wealth Management segment offers financial services, advice, and solutions; investment management, estate planning, and corporate advice services; and wealth management and banking products and services to private wealth and institutional customers. Its Personal & Corporate Banking segment provides banking, retirement, financing, investments, and strategic transactions to private, corporate, and institutional customers through its branch network and digital channels in Switzerland. The Asset Management segment offers diversified asset management services. Its Investment Bank segment provides equities, foreign exchange, precious metals, research, advisory, and capital markets services to institutional, corporate, financial sponsor, and Global Wealth Management customers, as well as focused rates and credit platform. The company also offers lending products, such as securities-based lending, mortgages, structured products, and tailored solutions; collateralized lending residential and commercial real estate, primarily against securities, residential and commercial real estate, other real assets (such as ships and aircraft), private market and hedge fund interest; and unsecured lending. The company was formerly known as UBS AG and changed its name to UBS Group AG in December 2014. UBS Group AG was founded in 1862 and is headquartered in Zurich, Switzerland.

UBS

Latest News

—

Caricamento notizie per UBS…

stock quote shares UBS – UBS Group AG Stock Price stock today

news today UBS – UBS Group AG stock forecast ,stock prediction 2023 2024 2025

marketwatch UBS – UBS Group AG yahoo finance google finance

stock history UBS – UBS Group AG invest stock market

stock prices UBS premarket after hours

ticker UBS fair value insiders trading

STM – STMicroelectronics N.V.

STM — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

1.34

Margin Of Safety %

Put/Call OI Ratio

0.71

EPS Next Q Diff

0.25

EPS Last/This Y

1.16

EPS This/Next Y

1.18

Price

56.12

Target Price

77.82

Analyst Recom

1.79

Performance Q

Upside

-68.8%

Beta

1.94

Ticker: STM

19 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-07-14	STM	70.16	0.78	0.37	332939
2026-07-15	STM	67.78	0.79	1.83	332494
2026-07-16	STM	62.8	0.78	0.45	334340
2026-07-17	STM	62.06	0.75	0.97	346816
2026-07-20	STM	62.47	0.84	0.23	272197
2026-07-21	STM	65.42	0.82	0.55	277265
2026-07-22	STM	65.7	0.82	0.50	285215
2026-07-23	STM	53.69	0.81	0.17	299967
2026-07-24	STM	51.53	0.73	0.75	327512
2026-07-27	STM	53.45	0.81	0.68	304132
2026-07-28	STM	50.16	0.82	0.43	311986
2026-07-29	STM	48.4	0.81	0.27	317513
2026-07-30	STM	53.05	0.77	0.63	338302
2026-07-31	STM	52.6	0.76	0.69	354597
2026-08-03	STM	52.19	0.82	2.50	340838
2026-08-04	STM	54.21	0.85	0.41	346134
2026-08-05	STM	52.71	0.82	0.10	366805
2026-08-06	STM	53.28	0.77	0.21	382696
2026-08-07	STM	56.1	0.71	0.41	407680
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

19 items 1 of 1

19 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-07-14	STM	70.15	343.7	949.0	1.28
2026-07-15	STM	67.76	343.7	922.9	1.28
2026-07-16	STM	62.79	343.7	874.9	1.28
2026-07-17	STM	62.08	343.7	928.4	1.28
2026-07-20	STM	61.79	343.7	979.1	1.28
2026-07-21	STM	65.42	343.7	1033.6	1.28
2026-07-22	STM	65.77	343.7	879.2	1.28
2026-07-23	STM	53.53	343.7	608.6	1.28
2026-07-24	STM	51.51	343.7	807.9	1.28
2026-07-27	STM	53.40	343.7	874.6	1.28
2026-07-28	STM	50.17	42.8	798.4	1.36
2026-07-29	STM	48.33	40.8	792.4	1.36
2026-07-30	STM	53.06	40.8	1019.4	1.36
2026-07-31	STM	52.34	40.8	869.1	1.35
2026-08-03	STM	52.21	40.8	517.8	1.35
2026-08-04	STM	52.21	40.8	517.8	1.35
2026-08-05	STM	52.72	40.8	449.9	1.35
2026-08-06	STM	53.24	40.8	500.7	1.35
2026-08-07	STM	56.12	40.8	531.5	1.35
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

19 items 1 of 1

18 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-07-14	STM	0	3.82	1.15
2026-07-15	STM	0	3.82	1.15
2026-07-16	STM	0	3.82	1.15
2026-07-17	STM	0	3.82	1.15
2026-07-20	STM	0	3.87	1.15
2026-07-21	STM	0	3.87	1.15
2026-07-22	STM	0	3.87	1.15
2026-07-23	STM	0	3.87	1.15
2026-07-24	STM	0	3.87	1.15
2026-07-27	STM	0	3.56	1.34
2026-07-28	STM	0	3.56	1.34
2026-07-29	STM	0	3.56	1.34
2026-07-30	STM	0	3.56	1.34
2026-07-31	STM	0	3.56	1.34
2026-08-03	STM	0	30.39	1.34
2026-08-04	STM	0	30.39	1.34
2026-08-06	STM	0	30.39	1.34
2026-08-07	STM	0	30.39	1.34
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

18 items 1 of 1

Last Quarter Act. EPS

0.31

Avg. EPS Est. Current Quarter

0.41

Avg. EPS Est. Next Quarter

0.56

Insider Transactions

Institutional Transactions

30.39

Beta

1.94

Average Sales Estimate Current Quarter

3745

Average Sales Estimate Next Quarter

4094

Fair Value

73.4

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

31.1

Max Drawdown 5-Year %

-66.7

Target Price

77.82

P/E

111.64

Forward P/E

20.94

PEG

0.22

P/S

3.83

P/B

2.83

P/Free Cash Flow

119.08

EPS

0.5

Average EPS Est. Cur. Y

1.35

EPS Next Y. (Est.)

2.53

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

3.55

Relative Volume

0.64

Return on Equity vs Sector %

-51

Return on Equity vs Industry %

-57.2

EPS 1 7Days Diff

EPS 1 30Days Diff

0.08

EBIT Estimation

531.5

◆ STM Technology

$56.10

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

6/20

Pullback

17/25

Volume

6/15

Valuation

18/20

TP/AR

5/10

Options

3/10

RSI

Range 1M

32.8%

Sup Dist

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

2/25

Growth

17/30

Estimates

10/20

Inst/Vol

5/15

Options

8/10

EPS Yr

154.7%

52W%

57.8%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +45.9% upside

Quality

5/30

Valuation

22/30

Growth

15/25

Stability

7/10

LT Trend

2/5

Upside

+45.9%

Quality

MoS

31%

STM — P/E HistoricalSemiconductors

STMicroelectronics N.V.

Sector: Technology

Industry: Semiconductors

Employees: 49000

STMicroelectronics N.V., together with its subsidiaries, designs, develops, manufactures, and sells semiconductor products in Europe, the Middle East, Africa, the Americas, and the Asia Pacific. The company operates through Analog products, MEMS and Sensors Group (AM&S); Power and Discrete products (P&D); Embedded Processing (EMP); and RF Products (D&RF) segments. It offers industrial application-specific integrated circuits (ASICs) and application-specific standard products (ASSPs); power management solutions; custom analog ICs, wireless charging solutions; galvanic isolated gate and LED drivers; converters, transistors, intelligent power switches, clocks and timers, comparators, and current-sense amplifiers; micro-electro-mechanical systems (MEMS) sensors, including accelerometers, gyroscopes, magnetic sensors, pressure, temperature, presence detection, biosensors, machine learning, and edge AI processing smart sensors, as well as thermal and piezoelectric actuators; and optical sensing solutions. The company also provides silicon MOSFETs, SiC MOSFETs, IGBTs, thyristors, rectifiers, and power modules and bipolar transistors; microcontrollers, and automotive microcontrollers and secured; radio frequency (RF) communications and ASICs; car infotainment products; ultra-wide band and radar systems; and Connected Security Products; and automotive driver assistance systems. It serves automotive, industrial, personal electronics and communications equipment, and computers and peripherals markets. STMicroelectronics N.V. was incorporated in 1987 and is headquartered in Schiphol, the Netherlands.

STM

Latest News

—

Caricamento notizie per STM…

stock quote shares STM – STMicroelectronics N.V. Stock Price stock today

news today STM – STMicroelectronics N.V. stock forecast ,stock prediction 2023 2024 2025

marketwatch STM – STMicroelectronics N.V. yahoo finance google finance

stock history STM – STMicroelectronics N.V. invest stock market

stock prices STM premarket after hours

ticker STM fair value insiders trading

No more stocks to show

ONC – BeOne Medicines Ltd ADR

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: ONC

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

AMRZ – Amrize Ltd

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: AMRZ

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

Last Quarter Act. EPS

Average EPS Est. Cur. Y

Last Quarter Act. EPS

Average EPS Est. Cur. Y

Last Quarter Act. EPS

Average EPS Est. Cur. Y